瑞巴派特,CAS 登记号 90098-04-7,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于医药中间体及原料药。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。
医药中间体及原料药
每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。
本页已列出 瑞巴派特 的 CAS 号:90098-04-7,可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。
主要涉及医药中间体及原料药。
来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。
Rebamipide · CAS 90098-04-7 · C19H15ClN2O4. UNII LR583V32ZR.
| CAS Registry Number | 90098-04-7 |
|---|---|
| PubChem CID | 5042 |
| Molecular formula | C19H15ClN2O4 |
| IUPAC name | 2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid |
| UNII (FDA) | LR583V32ZR |
| Molecular Weight | 370.8 |
|---|---|
| XLogP3 | 2.4 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 5 |
| Exact Mass | 370.0720347 |
| Monoisotopic Mass | 370.0720347 |
| Topological Polar Surface Area | 95.5 |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| GHS notification summary | 50% (1 / 2) |
|---|
| GHS notification summary | 50% (1 / 2) |
|---|---|
| Reported hazard statements | H301 (50%) |
This chemical does not meet GHS hazard criteria for 50% (1 of 2) of reports.
H301 (50%): Toxic if swallowed [Danger Acute toxicity, oral]
rebamipide; 90098-04-7; Proamipide; Mucosta; OPC-12759; Rebamipida; Rebator; Rebamipidum; 2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid; DTXSID8045937; OPC 12759; NSC-758955; LR583V32ZR; DTXCID6025937; 2-(4-chlorobenzoylamino)-3-(2(1H)-quinolinon-4-yl)propionic acid; 2-[(4-chlorophenyl)formamido]-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid
CAS 90098-04-7; molecular formula C19H15ClN2O4; molecular weight — g/mol.
rebamipide, 90098-04-7, Proamipide, Mucosta, OPC-12759, Rebamipida.
50% of GHS notifications report no hazard classification (1 of 2).
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.